NIF has an extensive network of Fellows and Associates across Australia. Thanks to this community, NIF expertly delivers advanced imaging solutions. Find out everything you want to know about imaging by reaching out to:
To learn more about the NIF organisation, head over to the About page or connect with us on social media:
The NIF Central Office is located within the University of Queensland in St Lucia, QLD, 4072. For general enquiries, please email firstname.lastname@example.org or contact the relevant Central Office staff, below.
Professor Graham Galloway is the Chief Executive Officer of the National Imaging Facility (NIF). He has been instrumental in establishing Imaging collaborative research infrastructure in Australia. In 2006, he led the collaborative team that developed the Investment plan for Imaging, within NCRIS (National Collaborative Research Infrastructure Strategy). This plan was accepted by Department of Industry, Innovation and Science, with $7M Commonwealth funding, plus $10M state and institutional funding and Galloway was nominated by the Imaging Community as the Inaugural Chief Executive Officer of the National Imaging Facility. In this role, he provides leadership to the NIF as it develops a strategic vision for imaging in Australia. Under his leadership, NIF has expanded through the Education Investment Fund and further capital investment through NCRIS. With state and institutional funding, this is a $130M project. He is passionate about providing open access to the imaging resources and enabling effective use of those resources.
Graham’s research interests include the use of in vivo Magnetic Resonance to test the efficacy of pharmaceutical agents, novel applications for the use of Magnetic Resonance in physiological studies and material sciences, and in pushing the boundaries of the technology into new applications. His role in all projects is characterised by his multidisciplinary background, which ensures that he is able to draw together these apparently disparate threads.
Telephone:+61 7 3343 7812
Mobile:+61 0 403 194 685
Saba manages the strategic planning and implementation of operations at the National Imaging Facility (NIF) which includes development and implementation of a new structure plan for NIF network, strategic management of NIF finance and project development, and establishing new processes that underpin collaborations and partnerships with wider communities and improve the operations of the network. She ensures effective implementation of the Facility’s goals in strengthening research outcomes through resource planning, management and continuous assessment of promotions, and development of business strategy.
Telephone:+61 7 3443 7831
Noni is the Manager for Engagement and Communications at the National Imaging Facility (NIF). She is responsible for NIF communications, stakeholder engagement, and marketing activities.
Noni is a researcher and communicator, passionate about growing and sharing knowledge to enhance wellbeing. Noni understands the research environment: she has worked in research institutes across Australia, Japan, Israel, Austria, and the UK. Her research breakthroughs in nanoelectronics applications and the development of new methods for assessing difficult-to-analyse diseased tissue have been published in leading scientific journals and presented at national and international forums. Since her journey ‘away from the bench’, Noni has developed expertise in engagement, marketing and communications. This has been achieved through a combination of formal qualifications and experience working with research and volunteer organisations. Noni’s excellent communication skills mean she has a flair for working with different groups to unlock and resolve core issues. It is these engagement skills that have allowed her to drive several complex and interdisciplinary collaborations to successful outcomes.
Mobile:+61 0 478 663 273
Rebecca (Bec) Dickson is the Senior Administration Officer for NIF. Bec completed a Bachelor of Business Management with UQ in 2003. She has been working in administration since 2004 and has worked for Connell Wagner, The Public Trustee of Queensland and Queensland Health. Bec has developed a multitude of skills, including budget creation and general finance, stakeholder liaison, secretariat, basic graphic design, word processing and events management.
Telephone:+61 7 3443 7815
Prof Price is Professor of Nanotechnology and directs the Biomedical Magnetic Resonance Facility at WUS. He has more than 20 years of experience in NMR. His research interests focus on the theoretical and practical development of NMR diffusion measurements and magnetic resonance imaging techniques for studying molecular association (e.g., drug binding and protein self-association) and molecular dynamics (including restricted diffusion in porous systems). He also has interests in the development and applications of MRI technology into areas such as studying freezing injury in plants.
Dr Carl Power is the Head of the Biological Resources Imaging Laboratory in the Mark Wainwright Analytical Centre. As head of BRIL, Dr Power has diverse interests in Preclinical imaging techniques including MRI, PET, CT, Optical Imaging and Ultrasound.In the area of cancer biology in general and specifically prostate cancer biology, research is focused on the use of animal models to identify mechanisms of prostate cancer metastasis to bone, immune responses to prostate cancer and its bone metastases and preclinical assessment of treatments to prevent bone mets.
Professor Rae is Professor of Brain Sciences at UNSW and has a background in biochemistry, magnetic resonance technologies and interdisciplinary brain research. Her research spans basic and clinical brain research with the overall aim of discovering how brain biochemistry underlies brain function. She has 20 years of experience in NMR and 15 years of experience in MR applications in vivo.
Professor Christou graduated from the University of Sydney with a Bachelor’s degree in Veterinary Science. After 20 years in private practice, Chris completed his PhD in Surgery (orthopaedics) at the University of New South Wales within a biomedical engineering laboratory.
Phone:+61 8 8128 4658
Professor Fernando Calamante is the Director of Sydney Imaging, the biomedical imaging Core Research Facility at the University of Sydney. He is also a Professor in the School of Biomedical Engineering. After he finished his BSc degree in Physics in Argentina, he went to study MRI in the UK as a Chevening Scholar (The British Council), where he later carried out his PhD at University College London. He relocated to Australia in 2005, where he spent 12 years at The Florey Institute of Neuroscience and Mental Health and the University of Melbourne. Fernando joined the University of Sydney in 2018. His main areas of research are Perfusion MRI and Diffusion MRI, and their applications to neurology and neuroscience. He has gained international recognition for his work on Perfusion MRI in particular, which is highly cited and at the forefront of the field. His Diffusion MRI methods are also widely used worldwide. Fernando has been elected to a number of leadership positions within the International Society for Magnetic Resonance in Medicine (ISMRM), included as Vice President-Elect in 2019.
Phone:+61 2 9114 4293
Professor Gary Egan is an NHMRC Principal Research Fellow and the Professor and Director of Monash Biomedical Imaging, a research platform that encompasses the biomedical imaging research facilities currently being established at Monash University. He is the Director of the ARC Centre of Excellence for Integrative Brain Function and has published over 220 papers and over 350 abstracts in peer-reviewed journals. He undertakes high resolution structural and functional brain mapping research and clinical neuroimaging research in Multiple Sclerosis and Huntington’s disease. He is also lead investigator of the Victorian Biomedical Imaging Capability and the Deputy Director of the Australian National Imaging Facility. For further information on Monash Biomedical Imaging (MBI) please refer to the MBI Website.
Professor Graeme Jackson is the Deputy Director of the Florey Neuroscience Institutes and Director of the Brain Research Institute, Australia. Graeme holds a number of other positions, both clinical and academic. He is a Professorial Fellow of the Department of Medicine, Austin Health, University of Melbourne. Professor Jackson’s major research achievement is his impact on the understanding of epilepsy. He is a world leader on the use of imaging technologies in neurological disease and has combined these interests to advance the understanding of epilepsy and to identify lesions that allow the surgical cure of epilepsy. He was awarded the National Health and Medical Research Council Excellence Award.
Associate Professor Leigh Johnston is the interim Director of the Melbourne Brain Centre Imaging Unit and a faculty member in the Department of Biomedical Engineering and Assistant Dean Research Training in the Melbourne School of Engineering. Prior to her appointment at the University of Melbourne, Leigh was a research fellow at York University in Canada and the Universite catholique de Louvain in Belgium. Leigh’s research interests are focussed on the development of improved imaging techniques for interrogating fundamental questions in neuroscience and include pulse design for high field MRI, statistical analysis methods for functional MRI connectivity mapping, biophysical modelling for diffusion-weighted MRI, and acquisition and analysis techniques for high-field sodium imaging.
Phone:+61 3 8344 1940
Professor Markus Barth has been awarded an ARC Future Fellowship in 2014 and leads the ultra-high-field human MR research program at the Centre for Advanced Imaging. He graduated from the Vienna University of Technology in Technical Physics in 1995 and was awarded his Doctorate in the Technical Sciences in 1999. He worked as a Senior Researcher at the Donders Institute for Brain, Cognition and Behaviour (Radboud University Nijmegen, NL) and at the Erwin L. Hahn Institute for Magnetic Resonance Imaging (University Essen-Duisburg, D). Markus relocated to Brisbane and the University of Queensland’s Centre for Advanced Imaging in 2014.
Prof Tom Johnstone joined the NIF network as the Node Director at Swinburne University of Technology in August 2018.
Following a BSc in physics at the University of Western Australia, Tom completed postgraduate research in cognitive science and psychology jointly at the University of Western Australia and University of Geneva, before postdoctoral research in cognitive neuroscience at the University of Wisconsin-Madison. For the last 11 years Tom has been at the University of Reading in the UK, where he headed the brain imaging facility.
Tom’s research focusses on the neural basis of cognition and emotion, in particular the role of cognitive and attentional processes in regulating emotion, and the interactions between the brain and the body that underlie emotional processes. His research includes studies of emotion regulation in healthy populations as well as in psychopathology, pain disorders and addiction.
Tom’s methodological focus is on developing data acquisition and analysis methods to integrate functional MRI, EEG and peripheral psychophysiology with behavioural measures. Tom is an enthusiastic supporter of interdisciplinary, open and collaborative science.
Phone:+61 3 9214 4345
Dr Bongers is a Facility Fellow who manages the flagship pre-clinical 9.4T MRI that is hosted by the Biomedical Resources & Imaging Laboratory (BRIL), University of New South Wales. Having obtained his PhD in 2004 in the field of Oxygen Level Dependent MRI, he brings 13+ years of experience in MRI methodology and application development into BRIL and NIF. With an impressive professional profile in both industry and academia, Andre focuses his research on the development of novel MRI methods for physiological and metabolic imaging in pre-clinical and clinical research. His current fields of interest include diffusion imaging using oscillating gradients, quantitative susceptibility mapping and chemical exchange transfer imaging and spectroscopy.
Dr Andrew Mehnert is Senior Lecturer in Data Management, Analysis and Visualisation at the Centre for Microscopy, Characterisation and Analysis (CMCA) at the University of Western Australia (UWA). His position is jointly funded by NIF and the Australian Microscopy & Microanalysis Research Facility (AMMRF). He provides informatics support (data management, analysis and visualisation) to, and collaborates with, CMCA researchers across various disciplines and microscopy and imaging techniques. Andrew’s research interests focus on the development of image analysis methods for biomedical imaging applications involving MRI, CT and optical microscopy. Such methods include visualisation, denoising, spatial co-registration, segmentation, parametric modelling of contrast enhancement (DCE-MRI), computational diffusion MRI and classification (feature extraction, feature selection and classifier design, training and validation).
Aswin Narayanan is a biomedical engineer with experience in software development, data analysis and commercialisation of research. He provides informatics support to the NIF Queensland node, through development and operation of data repositories, cloud services and imaging pipelines. Aswin has worked on various projects, including the NIF Trusted Data Repositories Project and the UQ CAMERA data framework.
Associate Professor Moffat is a medical imaging physicist and chemist with 19 years’ research experience in the Biomedical Imaging fields of MRI and Molecular Imaging. Since graduating from his PhD in 2001, he has made excellent and ongoing contributions to this field. He is currently deputy director of the Melbourne Brain Imaging Capability, The University of Melbourne node of the National Imaging Facility. He has specific expertise in quantitative Ultra High Field (7 Tesla) MR imaging of human subjects and Molecular Imaging biomarker research, development and clinical translation (Royal Melbourne Hospital 2007-14). He has published significant journal articles on fMRI, diffusion MRI, functional diffusion mapping, MR perfusion, MRS, voxel-based morphometry, PET and nano-theranostics.
Dr Brett Paterson obtained his PhD in chemistry from the University of Melbourne. He is a synthetic inorganic/organic chemist with extensive experience in the design, synthesis and evaluation of radiotracers/radiopharmaceuticals for therapy and imaging applications. His current research interests include synthesis; bioconjugation chemistry; radiochemistry; peptide synthesis; nanotechnology; diagnostic imaging and radiotherapy; and multidisciplinary translational research. Dr Paterson was awarded a Victoria Fellowship in 2011, which he used to conduct postdoctoral research and receive specialist training in radiochemistry, biology and molecular imaging at King’s College London and Boston Children’s Hospital/Harvard Medical School. He received a Victorian Postdoctoral Research Fellowship in 2013 and returned to King’s College London, where he was investigating targeted alpha therapy (TAT). Dr Paterson was a Discovery Early Career Researcher Award (DECRA) Fellow in the School of Chemistry, Monash University from 2017 to 2019. He has a research group within the School of Chemistry and leads the Radiochemistry Research Laboratory at Monash Biomedical Imaging.
Associate Professor David Abbott is a physicist-neuroscientist with over twenty years’ experience in neuroimaging informatics. He heads the Neuroinformatics Laboratory established in the Epilepsy and Imaging Divisions of the Florey Institute of Neuroscience and Mental Health. David develops enhanced national informatics capability in the processing, analysis and interpretation of neuroimaging data. Scope includes research, development, implementation and application of advanced analysis procedures; automated processing pipelines; image data management; policy development and education. David’s research has largely focussed on clinically relevant advances in human brain mapping. This includes pioneering work in electronic medical image distribution and neuroimaging methodology including structural and functional MRI analysis and simultaneous EEG/fMRI. David has authored over 100 cited publications in well-regarded international journals, with a cumulative citation count exceeding 5,000 according to Google Scholar. Portions of his research work are also embodied in publicly released software, including iBrain and the iBrain Analysis Toolbox for SPM (for image processing, analysis and visualisation), and SOCK (for fully automated noise classification and filtering of fMRI data).
Dr. Zheng completed his bachelor and Ph.D in Electrical Engineering at Nanjing University of Aeronautics and Astronautics in 2002 and 2007, respectively. Following graduation, he worked as a lecturer (2008) and associate professor (2014) at Nanjing University. In 2010, he joined the Department of Radiology at Jinling Hospital and conducted clinical research on hepatic encephalopathy based on fMRI under the supervision of Dr. Guangming Lu (Head of MRI team of the Chinese Society of Radiology). From 2013 to 2014, he went on to the Center for Functional Neuroimaging at the University of Pennsylvania under the supervision of Dr. Ze Wang, and participated in a project focused on arterial spin labelling MRI and brain connectome.
Currently, Gang is a pre-clinical MR physicist at Monash Biomedical Imaging. His clinical and pre-clinical research interests remain in metabolic brain diseases including hepatic encephalopathy, uremic encephalopathy and brain diseases caused by systemic lupus erythematosus. He is also interested in hyperpolarized 129Xe imaging in lung.
Dr Cowin develops new MR based projects on Bruker (9.4T large animal, 16.4T small animal micro-imaging system and 7T ClinScan systems) and Siemens human MRI systems (1.5T and 3T clinical and 7T research systems) for Human and Animal studies. He is also developing simultaneous PET and MRI imaging on the world’s first commercial prototype of a preclinical combined PET/MRI system. He has extensive experience investigating fat localisation and mobilisation, extending image resolution on ultra-high field Animal (16.4T) and Human (7T) MRI systems, prostate, liver and spinal cord research including spectroscopy, diffusion and anatomical imaging. Dr Cowin is experienced in various aspects of MRI QA, including effects of gradient non-linearity on image quality. He is developing hyperpolarised gas lung imaging in both human and animals, obtaining the first Helium images in Australia.
Georgia Williams is a Research Radiographer at Preclinical, Imaging and Research Laboratories (PIRL). Georgia graduated with a Bachelor of Medical Radiation Science (Medical Imaging) (Honours) from the University of South Australia in 2017. Before joining the team at PIRL, Georgia worked as a Diagnostic Radiographer at South Australia’s largest public hospital.
Giancarlo is an internationally renowned leader in radiopharmaceutical sciences, in particular, for the research and development of new tracers, radiochemical methods and automation strategies. His activities are focused on the use of cyclotron produced nuclides, but extend also to reactor and generator produced ones, as well as on-demand synthetic chemistry.
Dr Ivan Lozic is the Small Animal Imaging Specialist at the Centre for Microscopy, Characterisation and Analysis (CMCA) at the University of Western Australia (UWA). He provides training to new users at the CMCA, advising in experimental design, data acquisition and analysis. Ivan has worked in a range of scientific support roles, involving the use of a range of different analytical techniques: optical/confocal microscopy, fluorescence imaging, nano-scale mass spectrometry, NMR, ultrasound and CT. In addition, he has experience in the design and development of targeted therapeutic delivery nanoparticles and their multi-modal imaging in animal models. His interests involve the multidisciplinary application of complementary analytical and imaging techniques in biomedical research.
John has over 12 years’ experience in the field of radiopharmaceutical sciences (including basic sciences to clinical application). At his most recent long term position (2016-2019) he was employed as a Quality Assurance Officer / PET Development Radiochemist at the Clinical PET Centre, King’s College London (KCL). John has an interest and passion to deliver high quality radiopharmaceuticals in a public health and research environment including the development of novel and established radiopharmaceuticals for preclinical use and clinical use.
Dr Karine Mardon obtained her PhD in radiopharmacology from University Paris XII in 1994; she then moved to Australia to pursue postdoctoral studies at ANSTO in the Radiopharmaceutical Division and worked there for 5 years in the development and characterisation of radiopharmaceuticals for SPECT and PET. She has extensive experience with in vitro and in vivo preclinical research, particularly in the evaluation of drugs developed for the study of movement disorders as well as in the evaluation of radiolabelled peripheral benzodiazepine receptor ligands as markers of neurodegeneration and tumour occurrence. She moved to Brisbane in 2000 and joined the University of Queensland where she developed further experience working in the field of preclinical drug development in the ADME division of TetraQ. She joined the Centre for Advanced Imaging in October 2010 as NIF Facility Fellow for preclinical PET/CT.
Dr Matthew Hughes supports users on the 3T MRI. Dr Hughes provides support for a number of projects within Swinburne as well as collaborative projects.
Dr de Veer obtained his PhD in Biochemistry at Monash University and has extensive post-doctoral experience in signalling pathways, linking tracers and mapping cell migration and immune modulation within the lymphatic system. A large portion of his research is conducted with industry partners and he understands the interface between academic and translational research. He is currently leading the pre-clinical imaging team at Monash Biomedical Imaging and brings extensive experience with the large animal and rodent models that our users want to image. His own imaging research is aimed at developing MR and PET-MR imaging agents to delineate the lymphatic system in pre-clinical models of oedema and disease. He is an advocate for the benefits and impact of incorporating multi-modal imaging into projects to produce excellent research outcomes. A large part of his role is to facilitate industry engagement with the facility and drive translational research.
Dr Green assists researchers using the NeuRA 3T MRI system, including access, technical advice, data analysis, and imaging procedures. His research interests focus on MR diffusion imaging and analysis, as well as human brain MR Elastography imaging; an imaging sequence that examines the in-vivo viscoelastic nature of the brain as a potential indicator for brain disease.
Dr. Mitra Safavi-Naeini is the imaging quantification research leader at ANSTO. Before joining ANSTO in 2016, she completed her PhD in design and development of a prototype high-resolution SiPM-based PET system for preclinical imaging at the University of Wollongong, followed by an NHMRC postdoctoral fellowship in the design and development of an in-body source tracking system for use in brachytherapy.
Her current research interests include ultra-high-resolution positron emission tomography systems, Monte Carlo simulations of PET and related systems, advanced image reconstruction, quantification and optimisation techniques for tracer kinetic modelling and heavy ion therapy dose mapping.
Dr Oren Civier received his PhD from Boston University, where he used computational modelling to study cortical and subcortical mechanisms of speech production. After his PhD, Oren investigated white matter anomalies in speech disorders using diffusion MRI (DTI), and the neural control of oral and hand movements using MEG. Leveraging those qualifications and industry experience in Computer Science, Oren’s focus is on developing multimodal neuroimaging analysis tools based, in part, on the MRtrix software, including diffusion MRI combined with fMRI (continuing from his previous position at the University of Sydney), and diffusion MRI combined with MEG (current position). These efforts parallel his research interest in elucidating the brain’s connectivity network on multiple dimensions (conduction speed, throughput, redundancy, etc.) in order to develop more accurate diagnoses and more targeted/personalised treatment of brain disorders. Some additional research methodologies and techniques Dr Civier has used throughout his career are tDCS, electromagnetic/camera-based motion tracking, and auditory/visual feedback manipulation.
Raj Perumal has considerable experience in clinical diagnostic imaging and PACS administration. He holds an honours degree in Medical Imaging from the University of Teesside in the United Kingdom. As a human radiographer, he is responsible for the delivery of a high-quality imaging service in large animal preclinical research and human diagnostics by providing expertise in a range of imaging modalities, primarily 3TMR, 16-slice CT, X-ray and flat detector C-Arm for projects run at SAHMRI. His role covers assisting with setting up imaging protocols, planning, executing, analyzing and interpreting findings.
Dr Robert Smith completed Bachelors degrees in Applied Physics and Electronic Engineering at RMIT University in 2008 and has since completed a PhD and subsequent post-doctoral research at the Florey Institute of Neuroscience and Mental Health. His research focuses on the development of advanced processing and reconstruction methods for the analysis of diffusion MRI data, which enable robust inference of brain white matter connectivity and derivation of / inference on quantitative measures in the presence of complex white matter fibre configurations. These developments, in addition to other advanced data processing tools, are made freely available to the research community as part of the software package MRtrix3, for which extensive community support is provided via online forum and software teaching workshops. Dr Smith additionally provides support for the two 3T human MRI systems installed at the Melbourne Brain Centre in Heidelberg, which includes the recent Siemens Prisma scanner upgrade.
Rob Williams develops new methods, liaises with potential users and develops numerous PET/CT projects from scratch, some of which have resulted in high-level funding for the entire research community. He has continued to expand on developing the infrastructure, maintaining the procedure manuals, maintaining advanced life support qualifications and equipment, written complex database programs with multicenter access, and has performed the IT administration role of the imaging process servers, performed radiation audits, developed and performed advanced quality control, and assisted with symposia and multiple presentations. He coordinates all services and organizational entities related to the successful operation of the Unit, including the building and maintenance of relationships and ongoing interface with hospitals and universities, contractors, volunteers and students and benefactors. The Unit has significant influence in the terms of its technological capacity, investment and relevance to the identification of research leading to the development of longer-term therapeutic treatment of diseases such as Alzheimer’s. He has also engaged with researchers to develop new methodologies and prepare publications such as a blood pool imaging system or CT averaging for detailed images of objects or quantification methods of amyloid imaging using enhanced reconstruction methods.
Shawna Farquharson is the Chief Radiographer at The Florey Institute of Neuroscience and Mental Health, Austin campus. In her current role she is responsible for the delivery of research 3T & 7T MR based imaging, particularly functional MRI, EEG-fMRI, Spectroscopy, perfusion MRI and diffusion MRI for researchers within the Australian neuroscience community. Shawna was first given an opportunity to work in MRI whilst working as a senior radiographer at Great Ormond Street Hospital, London in 1997. Throughout her career, she has supported her diverse clinical expertise with continued postgraduate education. In 2001, she completed the Oxford MRI course at John Radcliffe Hospital, UK. In 2004, she gained the Australian Institute of Radiography Certificate of MRI Accreditation. In 2007, she completed a Masters of Health Science at the University of Sydney, Australia and is currently undertaking her PhD part-time through Monash University, Melbourne, Australia.
Dr Steffen Bollmann is a postdoctoral research fellow at the Centre for Advanced Imaging, UQ. He obtained a bachelor’s degree in science / biomedical engineering at the Ilmenau University of Technology, followed by a Masters degree in biomedical engineering & bioelectromagnetism. Following this, Steffen completed a PhD investigating multimodal imaging in ADHD children, adolescents and adults at the Neuroscience Centre Zurich and the Centre for MR-research, University Children’s Hospital Zurich. Steffen joined the Centre for Advanced Imaging, University of Queensland, in October 2014, where he is applying his expertise in multimodal imaging in the group of Prof. Markus Barth combining high-resolution quantitative imaging (susceptibility, T1, T2*), functional MRI (fMRI), and electroencephalography (EEG) with the goal to understand the relationship between functional networks and to work towards identifying early biomarkers for neurodegenerative diseases. Exploiting the high signal levels of ultra-high field 7 Tesla MRI he aims to investigate and quantify disease processes on a single subject level.
After completing his PhD in organic chemistry at the University of Wollongong in 2003, Tien accepted a position as a Post Doc at ANSTO. He then continued as a research scientist. In both roles, Tien was responsible for the synthesis and radiolabelling of small molecules, with 18F, 123I, 125I and 99mTc targeting cancer and neurodegenerative diseases. His main interests are in the development of radiochemistry and its translation into the clinic.
Dr Tim Rosenow is a physicist and the Facility Fellow for the 9.4T preclinical MRI at the University of Western Australia node. In his PhD he designed and optimised MRI sequences and low-dose CT protocols for detecting paediatric lung disease in humans. He has designed, validated and patented medical image analysis techniques for disease quantification in respiratory conditions. His current research interest is the use of novel MRI techniques to measure physiological processes and their behaviour in health and disease.
Dr Stait-Gardner is the Facility Fellow at the WSU node of the NIF where he oversees external use of the 11.7T MRI located at WSU’s Campbelltown campus. He also conducts his own research in NMR diffusometry which includes theoretical simulation and pulse sequence design and is interested in speeding up diffusion measurements significantly while still retaining other information such as chemical shifts. Such fast diffusion sequences will not only allow for much more efficient use of NMR spectrometers but will also extend the application of diffusion measurements into previously inaccessible time domains.
Dr Thomas Close specialises in neuroinformatics and computational neuroscience. He obtained a PhD investigating advanced techniques in diffusion MRI tractography of cerebral white matter and has completed a post-doctoral position in the Computational Neuroscience Unit of Okinawa Institute of Science and Technology Graduate University in Japan. Tom provides support for the imaging operations at Monash Biomedical Imaging by managing the relevant informatics software systems, helping researchers use and exploit the informatics software systems and leading a project to ensure the secure transfer of images between the Institute and hospital partners. Tom has also collaborated with other NIF Informatics Fellows on the national Trusted Data Repositories Project and developed a deployed exemplar utilizing the XNAT platform.
Biological Resources Imaging Laboratory (BRIL) is a facility with multimodal small animal imaging capabilities. The instruments include bioluminescence and fluorescence imaging, ultrasound and endoscopy. BRIL also houses a micro PET/CT and small animal 9.4T MRI.
Dr Hung assists researchers in the planning, imaging procedures and analysis of imaging data at BRIL. He is experienced in the development of preclinical murine cancer models and his research involves the use of multimodal small animal imaging for the monitoring, detection and analysis of prostate cancer bone metastasis.
I graduated with a PhD in chemistry from the University of Heidelberg, Germany in 1995. I spent a year as a Postdoc at Cornell University in Ithaca, NY, then worked as a medicinal chemist for Glaxosmithkline in Cape Town, South Africa.I joined Austin Health in 1998 as a radiochemist. Initially, I did a lot of carbon-11 work and established the procedure for the first C-11 PIB scan in Australia. I have extensive experience in performing first-in human studies with neuroscience and oncology tracers labelled with C-11, F-18 and Zr-89. My main research interests are in synthesis automation, labelling of peptides ad antibodies as well as hypoxia.
Wick Lakshantha is Imaging Scientist and NIF Fellow at LARIF. Wick received his PhD in Physics from the University of North Texas (UNT), where he studied radiation-matter interaction focused on applications towards material synthesis and characterisation at the Ion Beam Modification and Analysis Laboratory (IBMAL) at UNT. Later, He worked on the synthesis and characterisation of transition metal alloy thin films and nanostructures for structural, electronic, magnetic and surface properties.Currently, Wick works on small animal imaging with Micro-CT, MRI and PET/SPECT techniques.
Dr Will Woods received his degree in Applied Mathematics in 1991 and his PhD in 1995 in Chemical Engineering, both from the University of Newcastle upon Tyne, UK. From 1995 to 1997 he held an EU/JSPS Fellowship in the Department of Applied Mathematics at Kyoto University, Japan. He then worked on applications of minimal realisations of bilinear models to networks of neurons in the Department of Physiology in Newcastle upon Tyne, before moving to the University of York, UK in 2004 to facilitate the setup and management of only the second MEG lab in the UK. Since 2010 he has held the position of Senior Lecturer in Imaging at Swinburne University, Melbourne. His main research interests are applications of graph theoretic methods to neuroimaging data and inverse problems in MEG